MedTrace Logo

Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

NCT00099801 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2017-06-07

No results posted yet for this study

Summary

The safety and efficacy of FTY720 is being evaluated in patients who receive a kidney transplant.

Conditions

  • Kidney Transplantation

Interventions

DRUG

FTY720

Sponsors & Collaborators

Principal Investigators

  • Novartis · Novartis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2006-03-31
Completion
2006-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00099801 on ClinicalTrials.gov